跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,804 条关于
“ACVR2A/2B”
全部
2,804
临床试验
1,501
药物
117
机构
8
资讯
1,178
4个月前
Harbour BioMed's AI-Designed LET003 Shows Superior Obesity Treatment Potential in Preclinical Studies
上个月
Harbour BioMed Reports Seventh Consecutive Profitable Half-Year, Driven by Strategic Collaborations and AI-Enabled Pipeline Advances
11年前
Ropeginterferon Alfa-2b Shows Promise in Polycythemia Vera Treatment
3年前
Ropeginterferon Alfa-2b: Optimized Dosing Strategies Show Promise in Myeloproliferative Neoplasms
去年
Istaroxime Shows Promise in Improving Cardiac Function in Early Cardiogenic Shock
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
6年前
Ensifentrine Shows Promise in Improving Lung Function and COPD Symptoms
11年前
Ropeginterferon Alfa-2b Evaluated as Second-Line Therapy for High-Risk Essential Thrombocythemia in SURPASS-ET Trial
去年
Barinthus Bio Completes Enrollment in Phase 2b HBV003 and Phase 1 PCA001 Trials
3年前
Acelyrin's Izokibep Fails to Meet Primary Endpoint in Phase 2b/3 Hidradenitis Suppurativa Trial
第 1 页,共 118 页
上一页
下一页